ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline GWAV Q3 2023 Earnings Significant EPS Loss Amidst Operational Challenges STEL Q1 2026 Earnings Strong EPS Beat Amid Marginal Stock Decline Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development ARTNA Q3 2025 Earnings Slight EPS Beat Amid Steady Utility Performance NetSTREIT Corp NTST Q1 2026 Earnings EPS Misses Street View Shares Dip on Weaker Profitability